2019-nCoV Clinical Trial
Official title:
A Randomized, Open-label, Multi-centre Clinical Trial Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Confirmed Cases of Pneumonia Caused by Novel Coronavirus Infection
Base on Arbidol antiviral therapy,the investigators conduct a randomized, open-label trial to evaluate and compare the safety and efficacy of ASC09 /ritonavir and lopinavir/ritonavir in patients with 2019-nCoV pneumonia.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT04334967 -
Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care
|
Phase 4 | |
Not yet recruiting |
NCT04264858 -
Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients
|
N/A | |
Withdrawn |
NCT04272710 -
Prognositc Factors in COVID-19 Patients Complicated With Hypertension
|
||
Completed |
NCT04260594 -
Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus
|
Phase 4 | |
Active, not recruiting |
NCT04273763 -
Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)
|
N/A | |
Not yet recruiting |
NCT04270383 -
Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children
|
||
Not yet recruiting |
NCT04261426 -
The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia
|
Phase 2/Phase 3 | |
Recruiting |
NCT04254874 -
A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia
|
Phase 4 | |
Recruiting |
NCT04255017 -
A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia
|
Phase 4 | |
Not yet recruiting |
NCT04356508 -
COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1
|
Phase 2 | |
Terminated |
NCT04321928 -
Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary
|
N/A |